Complement-Fixing Anti-Type VII Collagen Antibodies Are Induced in Th1-Polarized Lymph Nodes of Epidermolysis Bullosa Acquisita-Susceptible Mice-Reference-Cited by-同舟云学术

Complement-Fixing Anti-Type VII Collagen Antibodies Are Induced in Th1-Polarized Lymph Nodes of Epidermolysis Bullosa Acquisita-Susceptible Mice

Published:2011-10-03 Issue:10 Volume:187 Page:5043-5050
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Hammers Christoph M.,Bieber Katja,Kalies Kathrin,Banczyk David,Ellebrecht Christoph T.,Ibrahim Saleh M.,Zillikens Detlef,Ludwig Ralf J.,Westermann Jürgen

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference44 articles.

1. Identification of the Skin Basement-Membrane Autoantigen in Epidermolysis Bullosa Acquisita

2. Epidermolysis Bullosa Acquisita Antigen, a New Major Component of Cutaneous Basement Membrane, Is a Glycoprotein with Collagenous Domains

3. Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen.

4. Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa.

5. Autoantibodies to Type VII Collagen Mediate Fcγ-Dependent Neutrophil Activation and Induce Dermal-Epidermal Separation in Cryosections of Human Skin

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of interferon gamma impairs induction of experimental epidermolysis bullosa acquisita;Frontiers in Immunology;2024-05-10

2. Psoriasis and other skin disorders;Feldman and Pike's Vitamin D;2024

3. Luteolin peracetate and gossypolone inhibit immune complex-mediated neutrophil activation in vitro and dermal-epidermal separation in an ex vivo model of epidermolysis bullosa acquisita;Frontiers in Immunology;2023-09-01

4. Epidermolysis Bullosa Acquisita—Current and Emerging Treatments;Journal of Clinical Medicine;2023-02-01

5. Autoimmune pre-disease;Autoimmunity Reviews;2023-02